SKI Market

Indian Indices

Nifty

25,330.25 91.15
(0.36%)

Sensex

83,013.96 320.25
( 0.39%)

Bank Nifty

55,493.30 345.70
( 0.63%)

Nifty IT

36,447.15 235.00
( 0.65%)

Global Indices

Nasdaq

46,015.42 236.51
(0.52%)

Dow Jones

6,617.88 9.88
(-0.15%)

Hang Seng

45,342.39 552.01
(1.23%)

Nikkei 225

9,208.37 12.71
(0.14%)

Forex

USD-INR

88.02 0.00
(0.00%)

EUR-INR

104.02 0.00
(0.00%)

GBP-INR

120.02 0.00
(0.00%)

JPY-INR

0.60 0.00
(0.00%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Divis Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

532488

INE361B01024

561.0868795

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

DIVISLAB

68.76

160625.75

EPS(TTM)

Face Value()

Div & Yield %

0.49

Back

divis laboratories ltd

Divi's Laboratories consolidated net profit rises 26.74% in the June 2025 quarter

Aug 08,2025

Net profit of Divi's Laboratories rose 26.74% to Rs 545.00 crore in the quarter ended June 2025 as against Rs 430.00 crore during the previous quarter ended June 2024. Sales rose 13.79% to Rs 2410.00 crore in the quarter ended June 2025 as against Rs 2118.00 crore during the previous quarter ended June 2024.

Particulars	Quarter Ended
	Jun. 2025	Jun. 2024	% Var.
Sales	2410.00	2118.00	14
OPM %	30.25	29.37	-
PBDT	845.00	701.00	21
PBT	733.00	604.00	21
NP	545.00	430.00	27

25,330.25 91.15 (0.36%)

83,013.96 320.25 ( 0.39%)

55,493.30 345.70 ( 0.63%)

36,447.15 235.00 ( 0.65%)

46,015.42 236.51 (0.52%)

6,617.88 9.88 (-0.15%)

45,342.39 552.01 (1.23%)

9,208.37 12.71 (0.14%)

88.02 0.00 (0.00%)

104.02 0.00 (0.00%)

120.02 0.00 (0.00%)

0.60 0.00 (0.00%)